[1] Krishnamurthi RV, Ikeda T, Feigin VL. Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage:a systematic analysis of the global burden of disease study 2017[J]. Neuroepidemiology, 2020, 54:171-179.
[2] Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, Su M, Zhao H, Spatz ES, Spertus JA, Masoudi FA, Krumholz HM, Jiang L. Prevalence, awareness, treatment, and control of hypertension in China:data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)[J]. Lancet, 2017, 390:2549-2558.
[3] Kim J, Bushnell CD, Lee HS, Han SW. Effect of adherence to antihypertensive medication on the long-term outcome after hemorrhagic stroke in Korea[J]. Hypertension, 2018, 72:391-398.
[4] Qureshi AI, Huang W, Lobanova I, Barsan WG, Hanley DF, Hsu CY, Lin CL, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Yamamoto H; for ATACH-Ⅱ trial investigators. Outcomes of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage and excessively high initial systolic blood pressure:post hoc analysis of a randomized clinical trial[J]. JAMA Neurol, 2020, 77:1-11.
[5] Zhang Y, Reilly KH, Tong W, Xu T, Chen J, Bazzano LA, Qiao D, Ju Z, Chen CS, He J. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China[J]. J Hypertens, 2008, 26:1446-1452.
[6] Jafari M, Damani R. Blood pressure variability and outcome after acute intracerebral hemorrhage[J]. J Neurol Sci, 2020, 413:116766.
[7] Mustanoja S, Putaala J, Koivunen RJ, Surakka I, Tatlisumak T. Blood pressure levels in the acute phase after intracerebral hemorrhage are associated with mortality in young adults[J]. Eur J Neurol, 2018, 25:1034-1040.
[8] Moullaali TJ, Wang X, Martin RH, Shipes VB, Robinson TG, Chalmers J, Suarez JI, Qureshi AI, Palesch YY, Anderson CS. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage:a preplanned pooled analysis of individual participant data[J]. Lancet Neurol, 2019, 18:857-864.
[9] Alrahbi S, Alaraimi R, Alzaabi A, Gosselin S. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage[J]. CJEM, 2018, 20:256-259.
[10] Wang X, Sandset EC, Moullaali TJ, Chen G, Song L, Carcel C, Delcourt C, Woodward M, Robinson T, Chalmers J, Arima H, Anderson CS; INTERACT2 Investigators. Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage[J]. J Hypertens, 2019, 37:1463-1466.
[11] Lin J, Piran P, Lerario MP, Ong H, Gupta A, Murthy SB, Díaz I, Stieg PE, Knopman J, Falcone GJ, Sheth KN, Fink ME, Merkler AE, Kamel H. Differences in admission blood pressure among causes of intracerebral hemorrhage[J]. Stroke, 2020, 51:644-647.
[12] Hemphill JC 3rd. Hematoma expansion in ICH:targeting epidemiology or biology[J]? Neurocrit Care, 2019, 31:9-10.
[13] Law ZK, Dineen R, England TJ, Cala L, Mistri AK, Appleton JP, Ozturk S, Bereczki D, Ciccone A, Bath PM, Sprigg N; TICH-2 Investigators. Predictors and outcomes of neurological deterioration in intracerebral hemorrhage:results from the TICH-2 randomized controlled trial[J]. Transl Stroke Res, 2020.[Epub ahead of print]
[14] Falcone GJ, Biffi A, Devan WJ, Brouwers HB, Anderson CD, Valant V, Ayres AM, Schwab K, Rost NS, Goldstein JN, Viswanathan A, Greenberg SM, Selim M, Meschia JF, Brown DL, Worrall BB, Silliman SL, Tirschwell DL, Rosand J; GOCHA Investigators. Burden of blood pressure-related alleles is associated with larger hematoma volume and worse outcome in intracerebral hemorrhage[J]. Stroke, 2013, 44:321-326.
[15] Wei L, Lin C, Zhou Z, Zhang J, Tan Q, Zhang Y, Zhang B, Ye D, Wu L, Liu Q, Xian J, Chen Z, Feng H, Zhu G. Analysis of different hematoma expansion shapes caused by different risk factors in patients with hypertensive intracerebral hemorrhage[J]. Clin Neurol Neurosurg, 2020, 194:105820.
[16] Melmed KR, Mondellini G, Roh D, Boehme A, Park S, Yuzefpolkya M, Naka Y, Uriel N, Agarwal S, Connolly ES, Claassen J, Colombo PC, Willey JZ. Clinical impact of hematoma expansion in left ventricular assist device patients[J]. World Neurosurg, 2020, 143:e384-390.
[17] Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, Heeley E, Skulina C, Parsons MW, Kim JS, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Heritier S, Morgenstern LB, Chalmers J; INTERACT Investigators. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT):a randomised pilot trial[J]. Lancet Neurol, 2008, 7:391-399.
[18] Anderson CS, Huang Y, Arima H, Heeley E, Skulina C, Parsons MW, Peng B, Li Q, Su S, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Morgenstern LB, Chalmers J, Wang JG; INTERACT Investigators. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage:the intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT)[J]. Stroke, 2010, 41:307-312.
[19] Toyoda K, Koga M, Yamamoto H, Foster L, Palesch YY, Wang Y, Sakai N, Hara T, Hsu CY, Itabashi R, Sato S, Fukuda-Doi M, Steiner T, Yoon BW, Hanley DF, Qureshi AI; ATACH-2 Trial Investigators. Clinical outcomes depending on acute blood pressure after cerebral hemorrhage[J]. Ann Neurol, 2019, 85:105-113.
[20] Jiang YJ. Analysis of the related risk factors for hematoma enlargement in acute stage of intracerebral hemorrhage[D]. Hengyang:University of South China, 2019.[蒋雅君. 脑出血急性期血肿扩大的相关危险因素分析[D]. 衡阳:南华大学, 2019.]
[21] Francoeur CL, Mayer SA; VISTA-ICH Collaborators. Acute blood pressure and outcome after intracerebral hemorrhage:the VISTA-ICH Cohort[J]. J Stroke Cerebrovasc Dis, 2021, 30:105456.
[22] Leasure AC, Qureshi AI, Murthy SB, Kamel H, Goldstein JN, Woo D, Ziai WC, Hanley DF, AI-Shahi Salman R, Matouk CC, Sansing LH, Sheth KN, Falcone GJ. Association of intensive blood pressure reduction with risk of hematoma expansion in patients with deep intracerebral hemorrhage[J]. JAMA Neurol, 2019, 76:949-955.
[23] Li Q, Warren AD, Qureshi AI, Morotti A, Falcone GJ, Sheth KN, Shoamanesh A, Dowlatshahi D, Viswanathan A, Goldstein JN. Ultra-early blood pressure reduction attenuates hematoma growth and improves outcome in intracerebral hemorrhage[J]. Ann Neurol, 2020, 88:388-395.
[24] Zhao JL, Du ZY, Sun YR, Yuan Q, Yu J, Wu X, Li ZQ, Wu XH, Xie R, Hu J. Intensive blood pressure control reduces the risk of progressive hemorrhage in patients with acute hypertensive intracerebral hemorrhage:a retrospective observational study[J]. Clin Neurol Neurosurg, 2019, 180:1-6.
[25] de Havenon A, Fino NF, Johnson B, Wong KH, Majersik JJ, Tirschwell D, Rost N. Blood pressure variability and cardiovascular outcomes in patients with prior stroke:a secondary analysis of PRoFESS[J]. Stroke, 2019, 50:3170-3176.
[26] Meeks JR, Bambhroliya AB, Meyer EG, Slaughter KB, Fraher CJ, Sharrief AZ, Bowry R, Ahmed WO, Tyson JE, Miller CC, Warach S, Khan BA, McCullough LD, Savitz SI, Vahidy FS. High in-hospital blood pressure variability and severe disability or death in primary intracerebral hemorrhage patients[J]. Int J Stroke, 2019, 14:987-995.
[27] Divani AA, Liu X, Di Napoli M, Lattanzi S, Ziai W, James ML, Jafarli A, Jafari M, Saver JL, Hemphill JC, Vespa PM, Mayer SA, Petersen A. Blood pressure variability predicts poor in-hospital outcome in spontaneous intracerebral hemorrhage[J]. Stroke, 2019, 50:2023-2029.
[28] Manning L, Hirakawa Y, Arima H, Wang X, Chalmers J, Wang J, Lindley R, Heeley E, Delcourt C, Neal B, Lavados P, Davis SM, Tzourio C, Huang Y, Stapf C, Woodward M, Rothwell PM, Robinson TG, Anderson CS; INTERACT2 investigators. Blood pressure variability and outcome after acute intracerebral haemorrhage:a post-hoc analysis of INTERACT2, a randomised controlled trial[J]. Lancet Neurol, 2014, 13:364-373.
[29] de Havenon A, Majersik JJ, Stoddard G, Wong KH, McNally JS, Smith AG, Rost NS, Tirschwell DL. Increased blood pressure variability contributes to worse outcome after intracerebral hemorrhage[J]. Stroke, 2018, 49:1981-1984.
[30] Chung PW, Kim JT, Sanossian N, Starkmann S, Hamilton S, Gornbein J, Conwit R, Eckstein M, Pratt F, Stratton S, Liebeskind DS, Saver JL; FAST-MAG Investigators and Coordinators. Association between hyperacute stage blood pressure variability and outcome in patients with spontaneous intracerebral hemorrhage[J]. Stroke, 2018, 49:348-354.
[31] Minhas JS, Wang X, Lavados PM, Moullaali TJ, Arima H, Billot L, Hackett ML, Olavarria VV, Middleton S, Pontes-Neto O, De Silva HA, Lee TH, Pandian JD, Mead GE, Watkins C, Chalmers J, Anderson CS, Robinson TG; HeadPoST Investigators. Blood pressure variability and outcome in acute ischemic and hemorrhagic stroke:a post hoc analysis of the HeadPoST study[J]. J Hum Hypertens, 2019, 33:411-418.
[32] Kim TJ, Park HK, Kim JM, Lee JS, Park SH, Jeong HB, Park KY, Rha JH, Yoon BW, Ko SB. Blood pressure variability and hemorrhagic transformation in patients with successful recanalization after endovascular recanalization therapy:a retrospective observational study[J]. Ann Neurol, 2019, 85:574-581.
[33] Jeon JP, Kim C, Kim SE. Blood pressure variability and outcome in patients with acute nonlobar intracerebral hemorrhage following intensive antihypertensive treatment[J]. Chin Med J (Engl), 2018, 131:657-664.
[34] Tanaka E, Koga M, Kobayashi J, Kario K, Kamiyama K, Furui E, Shiokawa Y, Hasegawa Y, Okuda S, Todo K, Kimura K, Okada Y, Okata T, Arihiro S, Sato S, Yamagami H, Nagatsuka K, Minematsu K, Toyoda K. Blood pressure variability on antihypertensive therapy in acute intracerebral hemorrhage:the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study[J]. Stroke, 2014, 45:2275-2279.
[35] Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, Lindley R, Robinson T, Lavados P, Neal B, Hata J, Arima H, Parsons M, Li Y, Wang J, Heritier S, Li Q, Woodward M, Simes RJ, Davis SM, Chalmers J; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage[J]. N Engl J Med, 2013, 368:2355-2365.
[36] Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) investigators. Antihypertensive treatment of acute cerebral hemorrhage[J]. Crit Care Med, 2010, 38:637-648.
[37] Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Ezzeddine MA, Goldstein JN, Hussein HM, Suri MF, Tariq N; Antihypertensive Treatment of Acute Cerebral Hemorrhage Study Investigators. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage:results from the antihypertensive treatment of acute cerebral hemorrhage study[J]. Arch Neurol, 2010, 67:570-576.
[38] Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage[J]. N Engl J Med, 2016, 375:1033-1043.
[39] Qureshi AI, Foster LD, Lobanova I, Huang W, Suarez JI. Intensive blood pressure lowering in patients with moderate to severe grade acute cerebral hemorrhage:post hoc analysis of antihypertensive treatment of acute cerebral hemorrhage (ATACH)-2 trial[J]. Cerebrovasc Dis, 2020, 49:244-252.
[40] Shoamanesh A, Morotti A, Romero JM, Oliveira-Filho J, Schlunk F, Jessel MJ, Ayres AM, Vashkevich A, Schwab K, Afzal MR, Cassarly C, Martin RH, Qureshi AI, Greenberg SM, Rosand J, Goldstein JN; Antihypertensive Treatment of Acute Cerebral Hemorrhage 2(ATACH-2) and the Neurological Emergencies Treatment Trials (NETT) Network Investigators. Cerebral microbleeds and the effect of intensive blood pressure reduction on hematoma expansion and functional outcomes:a secondary analysis of the ATACH-2 randomized clinical trial[J]. JAMA Neurol, 2018, 75:850-859.
[41] Butcher K, Jeerakathil T, Emery D, Dowlatshahi D, Hill MD,Sharma M, Buck B, Findlay M, Lee TY, Demchuk AM. The intracerebral haemorrhage acutely decreasing arterial pressure trial:ICH ADAPT[J]. Int J Stroke, 2010, 5:227-233.
[42] Gioia L, Klahr A, Kate M, Buck B, Dowlatshahi D, Jeerakathil T, Emery D, Butcher K. The Intracerebral Hemorrhage Acutely Decreasing Arterial pressure Trial Ⅱ (ICH ADAPT Ⅱ) protocol[J]. BMC Neurol, 2017, 17:100.
[43] Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, Forsting M, Harnof S, Klijn CJ, Krieger D, Mendelow AD, Molina C, Montaner J, Overgaard K, Petersson J, Roine RO, Schmutzhard E, Schwerdtfeger K, Stapf C, Tatlisumak T, Thomas BM, Toni D, Unterberg A, Wagner M; European Stroke Organisation. European stroke organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage[J]. Int J Stroke, 2014, 9:840-855.
[44] Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, Fung GL, Goldstein JN, Macdonald RL, Mitchell PH, Scott PA, Selim MH, Woo D; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46:2032-2060.
[45] Chinese Society of Neurology of Chinese Medical Association, Chinese Stroke Society of Chinese Society of Neurology of Chinese Medical Association. Chinese guidelines for diagnosis and treatment of acute intracerebral hemorrhage 2019[J]. Zhonghua Shen Jing Ke Za Zhi, 2019, 52:994-1005.[中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南(2019)[J]. 中华神经科杂志, 2019, 52:994-1005.]